Search CatalystAlert
Search for companies, drugs, and catalysts
Search CatalystAlert
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
0 competitors in Low Grade Ovarian Serous Adenocarcinoma
View Full LandscapeTarget Indication
Low Grade Ovarian Serous Adenocarcinoma
Clinical Trial
NCT04625270Last updated: 2/13/2026
No patent data available. Pre-approval drugs may not have Orange Book listings.
Low Grade Serous Ovarian Cancer
KRAS Activating Mutation
Low Grade Serous Ovarian Cancer
Non Small Cell Lung Cancer
Non Small Cell Lung Cancer